{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:32:53Z","timestamp":1794580373175,"version":"4.9.1"},"reference-count":53,"publisher":"American Society of Hematology","issue":"23","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,12,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Hydroxyurea reduces sickle cell disease (SCD) complications, but medication adherence is low. We tested 2 mobile health (mHealth) interventions targeting determinants of low adherence among patients (InCharge Health) and low prescribing among providers (HU Toolbox) in a multi-center, non-randomized trial of individuals with SCD ages 15-45. We compared the percentage of days covered (PDC), labs, healthcare utilization, and self-reported pain over 24 weeks of intervention and 12 weeks post-study with a 24-week preintervention interval. We enrolled 293 patients (51% male; median age 27.5 years, 86.8% HbSS\/HbS\u03b20-thalassemia). The mean change in PDC among 235 evaluable subjects increased (39.7% to 56.0%; P &amp;lt; 0.001) and sustained (39.7% to 51.4%, P &amp;lt; 0.001). Mean HbF increased (10.95% to 12.78%; P = 0.03). Self-reported pain frequency reduced (3.54 to 3.35 events\/year; P = 0.041). InCharge Health was used \u22651 day by 199 of 235 participants (84.7% implementation; median usage: 17% study days; IQR: 4.8-45.8%). For individuals with \u22651 baseline admission for pain, admissions per 24 weeks declined from baseline through 24 weeks (1.97 to 1.48 events\/patient, P = 0.0045) and weeks 25-36 (1.25 events\/patient, P\u00a0=\u00a00.0015). PDC increased with app use (P &amp;lt; 0.001), with the greatest effect in those with private insurance (P = 0.0078), older subjects (P = 0.033), and those with lower pain interference (P\u00a0=\u00a00.0012). Of the 89 providers (49 hematologists, 36 advanced care providers, 4 unreported), only 11.2% used HU Toolbox \u22651\/month on average. This use did not affect change in PDC. Tailoring mHealth solutions to address barriers to hydroxyurea adherence can potentially improve adherence and provide clinical benefits. A definitive randomized study is warranted. This trial was registered at www.clinicaltrials.gov as #NCT04080167.<\/jats:p>","DOI":"10.1182\/bloodadvances.2023010670","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T16:45:17Z","timestamp":1695401117000},"page":"7190-7201","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":20,"title":["A multilevel mHealth intervention boosts adherence to hydroxyurea in individuals with sickle cell disease"],"prefix":"10.1182","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4439-7321","authenticated-orcid":false,"given":"Jane S.","family":"Hankins","sequence":"first","affiliation":[{"name":"1Department of Global Pediatric Medicine, St. Jude Children's Research Hospital, Memphis, TN"},{"name":"2Center for Sickle Cell Disease, University of Tennessee Health Science Center, Memphis, TN"},{"name":"3Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Brambilla","sequence":"additional","affiliation":[{"name":"4RTI International, Research Triangle Park, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9930-392X","authenticated-orcid":false,"given":"Michael B.","family":"Potter","sequence":"additional","affiliation":[{"name":"5Department of Family and Community Medicine, University of California San Francisco School of Medicine, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdullah","family":"Kutlar","sequence":"additional","affiliation":[{"name":"6Center for Blood Disorders, Medical College of Georgia, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gibson","sequence":"additional","affiliation":[{"name":"6Center for Blood Disorders, Medical College of Georgia, Augusta University, Augusta, GA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1951-6176","authenticated-orcid":false,"given":"Allison A.","family":"King","sequence":"additional","affiliation":[{"name":"7Department of Pediatrics, Washington University in St. Louis, St. Louis, MO"},{"name":"8Division of Public Health Sciences, Department of Surgery, Washington University, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4523-0147","authenticated-orcid":false,"given":"Ana A.","family":"Baumann","sequence":"additional","affiliation":[{"name":"8Division of Public Health Sciences, Department of Surgery, Washington University, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Melvin","sequence":"additional","affiliation":[{"name":"9Department of Public Health Sciences, College of Medicine, Medical University of South Carolina, Charleston, SC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4725-7295","authenticated-orcid":false,"given":"Victor R.","family":"Gordeuk","sequence":"additional","affiliation":[{"name":"10Sickle Cell Center, University of Illinois at Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3156-2378","authenticated-orcid":false,"given":"Lewis L.","family":"Hsu","sequence":"additional","affiliation":[{"name":"10Sickle Cell Center, University of Illinois at Chicago, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1079-7829","authenticated-orcid":false,"given":"Chinonyelum","family":"Nwosu","sequence":"additional","affiliation":[{"name":"3Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0173-6522","authenticated-orcid":false,"given":"Jerlym S.","family":"Porter","sequence":"additional","affiliation":[{"name":"11Department of Psychology and Biobehavioral Sciences, St. Jude Children\u2019s Research Hospital, Memphis, TN"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7159-8156","authenticated-orcid":false,"given":"Nicole M.","family":"Alberts","sequence":"additional","affiliation":[{"name":"12Department of Psychology, Concordia University, Montreal, QC, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4739-265X","authenticated-orcid":false,"given":"Sherif M.","family":"Badawy","sequence":"additional","affiliation":[{"name":"13Division of Hematology, Oncology, and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL"},{"name":"14Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jena","family":"Simon","sequence":"additional","affiliation":[{"name":"15Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Glassberg","sequence":"additional","affiliation":[{"name":"15Department of Emergency Medicine, Icahn School of Medicine at Mount Sinai, New York, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9911-1138","authenticated-orcid":false,"given":"Richard","family":"Lottenberg","sequence":"additional","affiliation":[{"name":"16Department of Medicine, University of Florida, Gainesville, FL"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"DiMartino","sequence":"additional","affiliation":[{"name":"4RTI International, Research Triangle Park, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0617-4285","authenticated-orcid":false,"given":"Sara","family":"Jacobs","sequence":"additional","affiliation":[{"name":"4RTI International, Research Triangle Park, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7979-7379","authenticated-orcid":false,"given":"Maria E.","family":"Fernandez","sequence":"additional","affiliation":[{"name":"17Health Promotion and Behavioral Sciences, School of Public Health, The University of Texas Health Science Center at Houston, Houston, TX"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6188-9825","authenticated-orcid":false,"given":"Hayden B.","family":"Bosworth","sequence":"additional","affiliation":[{"name":"18Department of Population Health Studies, Duke University, Durham, NC"},{"name":"19Center of Innovation to Accelerate Discovery and Practice Transformation Durham Veterans Affairs Medical Center, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6237-4743","authenticated-orcid":false,"given":"Lisa M.","family":"Klesges","sequence":"additional","affiliation":[{"name":"8Division of Public Health Sciences, Department of Surgery, Washington University, St. Louis, MO"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7506-0935","authenticated-orcid":false,"given":"Nirmish","family":"Shah","sequence":"additional","affiliation":[{"name":"20Department of Pediatric Hematology and Oncology, Duke University, Durham, NC"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"issue":"6","key":"2023121116231403700_bib1","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.hoc.2022.06.008","article-title":"The evolving landscape of drug therapies for sickle cell disease","volume":"36","author":"Rai","year":"2022","journal-title":"Hematol Oncol Clin North Am"},{"issue":"9","key":"2023121116231403700_bib2","first-page":"CD002202","article-title":"Hydroxyurea (hydroxycarbamide) for sickle cell disease","volume":"9","author":"Rankine-Mullings","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"2023121116231403700_bib3","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/bjh.17687","article-title":"Hydroxyurea treatment and neurocognitive functioning in sickle cell disease from school age to young adulthood","volume":"195","author":"Heitzer","year":"2021","journal-title":"Br J Haematol"},{"key":"2023121116231403700_bib4","doi-asserted-by":"crossref","first-page":"2122056","DOI":"10.1155\/2022\/2122056","article-title":"Health-related quality of life and adherence to hydroxyurea and other disease-modifying therapies among individuals with sickle cell disease: a systematic review","volume":"2022","author":"Yang","year":"2022","journal-title":"Biomed Res Int"},{"issue":"11","key":"2023121116231403700_bib5","doi-asserted-by":"crossref","first-page":"e0141706","DOI":"10.1371\/journal.pone.0141706","article-title":"Hydroxyurea-increased fetal hemoglobin is associated with less organ damage and longer survival in adults with sickle cell anemia","volume":"10","author":"Fitzhugh","year":"2015","journal-title":"PLoS One"},{"issue":"6","key":"2023121116231403700_bib6","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1111\/bjh.12323","article-title":"The effect of hydroxcarbamide therapy on survival of children with sickle cell disease","volume":"161","author":"Lobo","year":"2013","journal-title":"Br J Haematol"},{"issue":"1","key":"2023121116231403700_bib7","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ajh.26765","article-title":"Impact of adherence to hydroxyurea on health outcomes among patients with sickle cell disease","volume":"98","author":"Kang","year":"2023","journal-title":"Am J Hematol"},{"issue":"1","key":"2023121116231403700_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12913-021-07461-6","article-title":"Cost analysis of acute care resource utilization among individuals with sickle cell disease in a middle-income country","volume":"22","author":"Lobo","year":"2022","journal-title":"BMC Health Serv Res"},{"issue":"6","key":"2023121116231403700_bib9","doi-asserted-by":"crossref","first-page":"e27721","DOI":"10.1002\/pbc.27721","article-title":"Hydroxyurea use among children with sickle cell anemia","volume":"66","author":"Reeves","year":"2019","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2023121116231403700_bib10","doi-asserted-by":"crossref","first-page":"e2128971","DOI":"10.1001\/jamanetworkopen.2021.28971","article-title":"Hydroxyurea use after transitions of care among young adults with sickle cell disease and Tennessee Medicaid Insurance","volume":"4","author":"Mathias","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"9","key":"2023121116231403700_bib11","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/pds.4860","article-title":"National trends in hydroxyurea and opioid prescribing for sickle cell disease by office-based physicians in the United States, 1997-2017","volume":"28","author":"Su","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"11","key":"2023121116231403700_bib12","first-page":"1412","article-title":"The association between hydroxyurea adherence and opioid utilization among Texas Medicaid enrollees with sickle cell disease","volume":"26","author":"Kang","year":"2020","journal-title":"J\u00a0Manag Care Spec Pharm"},{"issue":"3","key":"2023121116231403700_bib13","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1002\/ajh.21968","article-title":"Hydroxyurea adherence and associated outcomes among Medicaid enrollees with sickle cell disease","volume":"86","author":"Candrilli","year":"2011","journal-title":"Am J Hematol"},{"issue":"1","key":"2023121116231403700_bib14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/bjh.17953","article-title":"Bridging the implementation gap in medication adherence. If you build it, will they come?","volume":"196","author":"Hankins","year":"2022","journal-title":"Br J Haematol"},{"issue":"4","key":"2023121116231403700_bib15","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/jpepsy\/jsv084","article-title":"Systematic and meta-analytic review: medication adherence among pediatric patients with sickle cell disease","volume":"41","author":"Loiselle","year":"2016","journal-title":"J\u00a0Pediatr Psychol"},{"issue":"6","key":"2023121116231403700_bib16","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/ejh.12878","article-title":"Barriers to hydroxyurea adherence and health-related quality of life in adolescents and young adults with sickle cell disease","volume":"98","author":"Badawy","year":"2017","journal-title":"Eur J Haematol"},{"issue":"6","key":"2023121116231403700_bib17","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1542\/peds.2014-0177","article-title":"Medication adherence among pediatric patients with sickle cell disease: a systematic review","volume":"134","author":"Walsh","year":"2014","journal-title":"Pediatrics"},{"issue":"12","key":"2023121116231403700_bib18","doi-asserted-by":"crossref","first-page":"939","DOI":"10.7326\/0003-4819-148-12-200806170-00221","article-title":"Systematic review: hydroxyurea for the treatment of adults with sickle cell disease","volume":"148","author":"Lanzkron","year":"2008","journal-title":"Ann Intern Med"},{"issue":"1","key":"2023121116231403700_bib19","doi-asserted-by":"crossref","first-page":"e20183285","DOI":"10.1542\/peds.2018-3285","article-title":"Hydroxyurea use for sickle cell disease among Medicaid-enrolled children","volume":"144","author":"Brousseau","year":"2019","journal-title":"Pediatrics"},{"issue":"11","key":"2023121116231403700_bib20","doi-asserted-by":"crossref","first-page":"e050880","DOI":"10.1136\/bmjopen-2021-050880","article-title":"Identifying barriers to evidence-based care for sickle cell disease: results from the Sickle Cell Disease Implementation Consortium cross-sectional survey of healthcare providers in the USA","volume":"11","author":"Smeltzer","year":"2021","journal-title":"BMJ Open"},{"issue":"5","key":"2023121116231403700_bib21","doi-asserted-by":"crossref","first-page":"e206016","DOI":"10.1001\/jamanetworkopen.2020.6016","article-title":"Perceptions of US adolescents and adults with sickle cell disease on their quality of care","volume":"3","author":"Kanter","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"5","key":"2023121116231403700_bib22","doi-asserted-by":"crossref","first-page":"e14884","DOI":"10.2196\/14884","article-title":"Development of the InCharge Health mobile app to improve adherence to hydroxyurea in patients with sickle cell disease: user-centered design approach","volume":"8","author":"Alberts","year":"2020","journal-title":"JMIR Mhealth Uhealth"},{"issue":"18","key":"2023121116231403700_bib23","doi-asserted-by":"crossref","first-page":"4463","DOI":"10.1182\/bloodadvances.2020001701","article-title":"Intentional and unintentional nonadherence to hydroxyurea among people with sickle cell disease: a qualitative study","volume":"4","author":"Hodges","year":"2020","journal-title":"Blood Adv"},{"key":"2023121116231403700_bib24","volume-title":"Health Behaviour and Health Education: Theory, Research and Practice","author":"Stretcher","year":"1997"},{"key":"2023121116231403700_bib25","first-page":"349","author":"Bandura","year":"2012"},{"issue":"7","key":"2023121116231403700_bib26","doi-asserted-by":"crossref","first-page":"e16319","DOI":"10.2196\/16319","article-title":"Integration of mobile health into sickle cell disease care to increase hydroxyurea utilization: protocol for an efficacy and implementation study","volume":"9","author":"Hankins","year":"2020","journal-title":"JMIR Res Protoc"},{"issue":"3","key":"2023121116231403700_bib27","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/pds.3935","article-title":"Estimating time-varying drug adherence using electronic records: extending the proportion of days covered (PDC) method","volume":"25","author":"Bijlsma","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"2023121116231403700_bib28","unstructured":"Centers for Medicare and Medicaid Services. 2023 Medicare-Medicaid Plan Performance Data Technical Notes. 2022. Accessed 27 December 2022. https:\/\/www.cms.gov\/files\/document\/mmpperformancedatatechnotes.pdf."},{"issue":"12","key":"2023121116231403700_bib29","doi-asserted-by":"crossref","first-page":"E391","DOI":"10.1002\/ajh.25282","article-title":"The sickle cell disease implementation consortium: translating evidence-based guidelines into practice for sickle cell disease","volume":"93","author":"DiMartino","year":"2018","journal-title":"Am J Hematol"},{"key":"2023121116231403700_bib30","author":"Bosworth","year":"2014"},{"key":"2023121116231403700_bib31","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/s12955-014-0125-0","article-title":"Patient reports of health outcome for adults living with sickle cell disease: development and testing of the ASCQ-Me item banks","volume":"12","author":"Keller","year":"2014","journal-title":"Health Qual Life Outcomes"},{"issue":"2","key":"2023121116231403700_bib32","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1108\/IJPHM-06-2016-0029","article-title":"Sensitivity of alternative measures of functioning and wellbeing for adults with sickle cell disease: comparison of PROMIS(R) to ASCQ-MeSM","volume":"11","author":"Keller","year":"2017","journal-title":"Int J Pharm Healthc Mark"},{"issue":"6","key":"2023121116231403700_bib33","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1002\/pbc.25944","article-title":"Initial evaluation of the pediatric PROMIS(R) health domains in children and adolescents with sickle cell disease","volume":"63","author":"Dampier","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"2023121116231403700_bib34","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jval.2016.02.009","article-title":"A\u00a0PROMIS measure of neuropathic pain quality","volume":"19","author":"Askew","year":"2016","journal-title":"Value Health"},{"issue":"7","key":"2023121116231403700_bib35","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1007\/s11136-017-1527-3","article-title":"Validation of the PROMIS((R)) measures of self-efficacy for managing chronic conditions","volume":"26","author":"Gruber-Baldini","year":"2017","journal-title":"Qual Life Res"},{"issue":"3","key":"2023121116231403700_bib36","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s11136-011-9958-8","article-title":"Neuro-QOL: quality of life item banks for adults with neurological disorders: item development and calibrations based upon clinical and general population testing","volume":"21","author":"Gershon","year":"2012","journal-title":"Qual Life Res"},{"key":"2023121116231403700_bib37","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/frhs.2022.1024541","article-title":"Evaluating the implementation of a multi-level mHealth study to improve hydroxyurea utilization in sickle cell disease","volume":"2","author":"Hankins","year":"2023","journal-title":"Front Health Serv"},{"key":"2023121116231403700_bib38","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.rmed.2019.02.011","article-title":"Impact of eHealth on medication adherence among patients with asthma: a systematic review and meta-analysis","volume":"149","author":"Jeminiwa","year":"2019","journal-title":"Respir Med"},{"issue":"4","key":"2023121116231403700_bib39","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.amepre.2021.11.003","article-title":"Mobile health applications and medication adherence of patients with hypertension: a systematic review and meta-analysis","volume":"62","author":"Mikulski","year":"2022","journal-title":"Am J Prev Med"},{"issue":"9","key":"2023121116231403700_bib40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.115.015373","article-title":"A\u00a0cluster-randomized, controlled trial of a simplified multifaceted management program for individuals at high cardiovascular risk (SimCard Trial) in rural Tibet, China, and Haryana, India","volume":"132","author":"Tian","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"2023121116231403700_bib41","doi-asserted-by":"crossref","first-page":"e24190","DOI":"10.2196\/24190","article-title":"Mobile apps to improve medication adherence in cardiovascular disease: systematic review and meta-analysis","volume":"23","author":"Al-Arkee","year":"2021","journal-title":"J\u00a0Med Internet Res"},{"issue":"3","key":"2023121116231403700_bib42","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1001\/jamainternmed.2015.7667","article-title":"Mobile telephone text messaging for medication adherence in chronic disease: a meta-analysis","volume":"176","author":"Thakkar","year":"2016","journal-title":"JAMA Intern Med"},{"issue":"7933","key":"2023121116231403700_bib43","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/s41586-022-05312-w","article-title":"Activation of gamma-globin expression by hypoxia-inducible factor 1alpha","volume":"610","author":"Feng","year":"2022","journal-title":"Nature"},{"issue":"10","key":"2023121116231403700_bib44","doi-asserted-by":"crossref","first-page":"e41415","DOI":"10.2196\/41415","article-title":"Impact of the COVID-19 pandemic on the implementation of mobile health to improve the uptake of hydroxyurea in patients with sickle cell disease: mixed methods study","volume":"6","author":"Badawy","year":"2022","journal-title":"JMIR Form Res"},{"issue":"8","key":"2023121116231403700_bib45","doi-asserted-by":"crossref","first-page":"e2014650","DOI":"10.1001\/jamanetworkopen.2020.14650","article-title":"Comparative effectiveness of community-based vs clinic-based healthy choices motivational intervention to improve health behaviors among youth living with HIV: a randomized clinical trial","volume":"3","author":"Naar","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2023121116231403700_bib46","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1016\/j.pec.2022.06.013","article-title":"Motivational interviewing to support medication adherence in adults with chronic conditions: systematic review of randomized controlled trials","volume":"105","author":"Papus","year":"2022","journal-title":"Patient Educ Couns"},{"issue":"2","key":"2023121116231403700_bib47","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/bjh.14956","article-title":"Understanding patterns and correlates of daily pain using the sickle cell disease mobile application to record symptoms via technology (SMART)","volume":"183","author":"Jonassaint","year":"2018","journal-title":"Br J Haematol"},{"issue":"10","key":"2023121116231403700_bib48","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/tbm\/ibab041","article-title":"Mobile health use predicts self-efficacy and self-management in adolescents with sickle cell disease","volume":"11","author":"Hood","year":"2021","journal-title":"Transl Behav Med"},{"issue":"7","key":"2023121116231403700_bib49","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1037\/amp0000983","article-title":"Engagement in digital interventions","volume":"77","author":"Nahum-Shani","year":"2022","journal-title":"Am Psychol"},{"issue":"7","key":"2023121116231403700_bib50","doi-asserted-by":"crossref","first-page":"e2010918","DOI":"10.1001\/jamanetworkopen.2020.10918","article-title":"Digital health and engagement-looking behind the measures and methods","volume":"3","author":"Torous","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"2023121116231403700_bib51","doi-asserted-by":"crossref","first-page":"e0272204","DOI":"10.1371\/journal.pone.0272204","article-title":"What does it mean to be affiliated with care?: Delphi consensus on the definition of \"unaffiliation\" and \"specialist\" in sickle cell disease","volume":"17","author":"Lamont","year":"2022","journal-title":"PLoS One"},{"key":"2023121116231403700_bib52","author":"Shadish","year":"2002"},{"issue":"11","key":"2023121116231403700_bib53","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1002\/ajh.26315","article-title":"Patient-reported neurocognitive symptoms influence instrumental activities of daily living in sickle cell disease","volume":"96","author":"Longoria","year":"2021","journal-title":"Am J Hematol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/23\/7190\/2176222\/blooda_adv-2023-010670-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/7\/23\/7190\/2176222\/blooda_adv-2023-010670-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T16:40:55Z","timestamp":1702312855000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/7\/23\/7190\/498036\/A-multilevel-mHealth-intervention-boosts-adherence"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":53,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2023,12,12]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2023010670","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}